
ODIN Diagnostics is a pioneering company focused on real-time concussion detection through advanced eye-tracking technology and machine learning algorithms. Their product provides immediate, interpretable results that empower athletes, coaches, and medical professionals to make informed decisions during critical moments. With a commitment to enhancing athlete safety, ODIN's solution is designed for instant use on the sidelines, ensuring that concussions are detected and managed effectively. The company aims to revolutionize concussion care across all ages, setting a new standard in sports safety and health.

ODIN Diagnostics is a pioneering company focused on real-time concussion detection through advanced eye-tracking technology and machine learning algorithms. Their product provides immediate, interpretable results that empower athletes, coaches, and medical professionals to make informed decisions during critical moments. With a commitment to enhancing athlete safety, ODIN's solution is designed for instant use on the sidelines, ensuring that concussions are detected and managed effectively. The company aims to revolutionize concussion care across all ages, setting a new standard in sports safety and health.
Core product: AI-powered eye-tracking device and software for rapid, non-invasive concussion assessment
Stage: Pre-Seed (investigational device; not FDA-cleared)
Headquarters: San Luis Obispo, California
Team size: Approximately 6 employees
Concussion detection and acute brain injury assessment in sports and point-of-care settings
Health diagnostics / Medical devices
Crunchbase lists a Pre-Seed round announced Sep 4, 2024; public profiles obfuscate amount and investor names.